S&P 500
$5,844.61
-1.6%
-$95.85
DJI
41,860.44
-1.9%
-816.80
NASDAQ
$18,872.64
-1.4%
-$270.07
Bitcoin
111,036.00
+4.2%
+4,508.85
AAPL
$202.42
-2.1%
-$4.44
AMZN
$201.35
-1.3%
-$2.72
GOOG
$170.25
+3.0%
+$4.93
META
$635.69
-0.2%
-$1.41
MSFT
$453.22
-1.1%
-$4.95
NVDA
$131.94
-1.8%
-$2.44
TSLA
$334.80
-2.6%
-$9.02
Rubius Therapeutics (OTC: RUBY)
Some price data may be temporarily unavailable.
Rubius Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rubius Therapeutics Company Info
Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA.
News & Analysis
Featured Article
Why Rubius Therapeutics Stock Is Skyrocketing Today
The company announced positive results from a clinical trial.
Prosper Junior Bakiny | Mar 15, 2021
Featured Article
3 High-Risk, High-Reward Stocks to Add to Your Watch List
These biotechs have a long road ahead, but they just might deliver massive growth.
Alex Carchidi | Sep 22, 2020
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.